Education
About Us
Working with TipRanks
Follow Us
PT Kalbe Farma Tbk (PTKFF)
OTHER OTC:PTKFF
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $3.07B. The enterprise value is $2.96B.
Market Cap$3.07B
Enterprise Value$2.96B
Share Statistics
PT Kalbe Farma Tbk has 46,813,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,813,390,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.23%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)12.23%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee2.54B
Profits Per Employee0.00
Employee Count12,841
Asset Turnover1.11
Inventory Turnover3.03
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 14.9. PT Kalbe Farma Tbk’s PEG ratio is ―.
PE Ratio14.9
PS Ratio0.00
PB Ratio0.00
Price to Fair Value3.10
Price to FCF0.00
Price to Operating Cash Flow14.42
PEG Ratio―
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 32.63T and earned 3.24T in profits. Earnings per share was 70.22.
Revenue32.63T
Gross Profit12.96T
Operating Income4.07T
Pretax Income4.22T
Net Income3.24T
EBITDA4.61T
Earnings Per Share (EPS)70.22
Cash Flow
In the last 12 months, operating cash flow was 3.45T and capital expenditures -746.67B, giving a free cash flow of 2.71T billion.
Operating Cash Flow3.45T
Free Cash Flow2.71T
Free Cash Flow per Share57.81
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.002, resulting in a dividend yield of 3.09%
Dividend Per Share$0.002
Dividend Yield3.09%
Payout Ratio54.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change-7.89%
50-Day Moving Average0.07
200-Day Moving Average0.08
Relative Strength Index (RSI)13.73
Average Volume (3m)136.00
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateOct 28, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
PT Kalbe Farma Tbk as a current ratio of 4.11, with Debt / Equity ratio of 2.27%
Current Ratio4.11
Quick Ratio2.55
Debt to Market Cap<0.01
Net Debt to EBITDA-0.90
Interest Coverage Ratio72.22
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 972.30B in taxes.
Income Tax972.30B
Effective Tax Rate0.23
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 14.40, with an EV/FCF ratio of 18.80.
EV to Sales2.04
EV to EBITDA14.40
EV to Free Cash Flow18.80
EV to Operating Cash Flow13.89
Balance Sheet
PT Kalbe Farma Tbk has $4.18T in cash and marketable securities with $531.72B in debt, giving a net cash position of $3.66T billion.
Cash & Marketable Securities$4.18T
Total Debt$531.72B
Net Cash$3.66T
Net Cash Per Share$78.18
Tangible Book Value Per Share$481.89
Margins
Gross margin is 40.32%, with operating margin of 12.47%, and net profit margin of 9.93%.
Gross Margin40.32%
Operating Margin12.47%
Pretax Margin12.93%
Net Profit Margin9.93%
EBITDA Margin14.14%
EBIT Margin13.10%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―